DA Davidson reiterates Buy rating on Private Bancorp of America stock

Published 22/07/2025, 15:34
DA Davidson reiterates Buy rating on Private Bancorp of America stock

Investing.com - DA Davidson has reiterated its Buy rating and $75.00 price target on Private Bancorp of America (OTC:PBAM) stock following the company’s second-quarter results. Currently trading at $58, the stock sits within a broader analyst target range of $68-$80, with InvestingPro data showing 3 analysts recently revising earnings estimates upward.

The firm noted that Private Bancorp’s second-quarter performance exceeded expectations, primarily driven by net interest margin expansion, even when excluding the positive impact of interest recoveries during the quarter. The company’s strong execution is reflected in its 22.32% revenue growth and attractive P/E ratio of 8.15x.

DA Davidson views management’s disciplined approach to loan pricing as a long-term positive for the company, despite potentially restraining near-term loan growth compared to Private Bancorp’s historical trends.

The research firm expects Private Bancorp to maintain its focus on improving its funding base, building new client relationships, and pursuing other internal improvements.

Private Bancorp of America trades on the over-the-counter market under the ticker PBAM, with DA Davidson maintaining both its Buy recommendation and $75 price target on the stock.

In other recent news, DA Davidson has reiterated its Buy rating for Private Bancorp of America. The firm has set a price target of $75.00 for the company’s stock. Private Bancorp’s first-quarter results surpassed expectations, with net interest income performing better than anticipated. These developments indicate a positive outlook from DA Davidson, highlighting the company’s financial performance. The emphasis on net interest income suggests that the company has managed its financial operations effectively during the quarter. Investors may find this information relevant as it provides insights into the company’s recent financial health. These updates reflect the ongoing evaluation and analysis by financial firms like DA Davidson.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.